Shares of Santarus Inc. (NASDAQ: SNTS), a specialty biopharmaceutical company, surged in trading on Friday after the company agreed to be acquired by Salix Pharmaceuticals Ltd. (NASDAQ: SXLP). The two companies entered into a definitive agreement under which SLXP will acquire all outstanding shares of Santarus for $32 per share in cash. The offer price from Salix represents a premium of 36% over Santarus’ closing price on November 6, 2013. Santarus shares ended the day 37.60% higher at $31.95 on above average volume of 45.22 million. SLXP shares, meanwhile, ended the day 17.80% higher at $84 on above average volume of 6.64 million.
Tag: SNTS
Major Movers on July 8; LINE, TRQ, SNTS, UNH, FB
Shares of Linn Energy LLC (NASDAQ: LINE) rallied about 12% by mid-day trade. Bank of America Merrill Lynch upgraded the oil and gas firm’s rating to “buy” from “neutral”, citing company’s attractive valuation and said that cash flows are sustainable.
Continue reading Major Movers on July 8; LINE, TRQ, SNTS, UNH, FB
Major Movers on May 7; FSLR, FOSL, MELI, RKUS, ARUN, SNTS, EOG, DTV
Shares of First Solar Inc. (NASDAQ: FSLR) fell about 9.25% by afternoon trade. Although the solar panel maker, late last evening, reported that it swung into fiscal first quarter profit and handed revenue which edged past Street’s consensus estimate, investors were disappointed as adjusted earnings fell short of expectation. However, the Company maintained its full-year earnings and revenue guidance which exceeded analysts’ consensus estimate.
Continue reading Major Movers on May 7; FSLR, FOSL, MELI, RKUS, ARUN, SNTS, EOG, DTV
Santarus Shares Surge on FDA Approval of UCERIS (SNTS)
Shares of Santarus Inc. (NASDAQ: SNTS), a specialty biopharmaceutical company engaged in the acquisition, development and commercialization of products that address the needs of patients treated by physician specialists, surged on Tuesday after the company received FDA approval of UCERIS™ (budesonide) for the induction of remission in patients with active, mild to moderate ulcerative colitis.
Continue reading Santarus Shares Surge on FDA Approval of UCERIS (SNTS)
Major Movers on January 15; LULU, DELL, AAPL, FRX, SNTS
Shares of Lululemon Athletica Inc. (NASDAQ: LULU) slumped on Tuesday after the yoga and athletic apparel retailer late on Monday boosted its earnings projections for fiscal fourth quarter but remained in line with Street’s estimate and missed analysts’ revenue expectations.
Continue reading Major Movers on January 15; LULU, DELL, AAPL, FRX, SNTS